CYTKNasdaqSEC EDGAREDGAR

CYTOKINETICS INC

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA·FY end 12/31·CIK 1061983

Board of Directors

3 members · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Edward M. Kaye, M.D.Director
Wendell Wierenga, Ph.D.Director
Nancy J. WysenskiDirector

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.